Skip to main navigation Skip to search Skip to main content

Schizophrenia, chronic hospitalization and the 5-HT(2C) receptor gene

  • R. H. Segman
  • , R. P. Ebstein
  • , U. Heresco-Levy
  • , M. Gorfine
  • , M. Avnon
  • , E. Gur
  • , L. Nemanov
  • , B. Lerer
  • Hadassah University Medical Centre
  • Herzog Hospital Jerusalem
  • Hebrew University of Jerusalem
  • Sha'ar Menashe Mental Health Center

Research output: Contribution to journalArticlepeer-review

36 Scopus citations

Abstract

Frequency of a polymorphism in the coding region of the 5-hydroxytryptamine(2C) (5-HT(2C)) receptor gene (HTR2C Xq24) was not significantly different in 122 unrelated Israeli schizophrenia patients compared with 180 control subjects matched for gender and ethnicity. However, proportion of time spent in hospital since the first admission was significantly greater in patients hemi- or homozygous for the 5-HT(2Cser) allele than in patients carrying other genotypes (p = 0.006). The 5-HT(2Cser) genotype conferred a 3.3-fold increased risk for lifetime hospitalization exceeding 10 years. Genetically determined variation in the 5-HT(2C) receptor may influence the clinical course and phenotypic expression of schizophrenia.

Original languageEnglish
Pages (from-to)75-78
Number of pages4
JournalPsychiatric Genetics
Volume7
Issue number2
DOIs
StatePublished - 1997
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • 5-HT(2c) receptor polymorphism
  • Chronic hospitalization
  • Genetic association
  • Schizophrenia
  • Serotonin

Fingerprint

Dive into the research topics of 'Schizophrenia, chronic hospitalization and the 5-HT(2C) receptor gene'. Together they form a unique fingerprint.

Cite this